Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:52 AM
Ignite Modification Date:
2025-12-25 @ 3:52 AM
NCT ID:
NCT00034502
Eligibility Criteria:
Inclusion Criteria:
* Histologic or cytologic diagnosis of locally or metastatic colorectal cancer
* Prior therapy with 5-FU for metastatic cancer
* Adequate bone marrow, liver and kidney function
Exclusion Criteria:
* Pregnancy
* Breast feeding
* Inability to interrupt aspirin therapy
* Brain metastasis
* Patients who have been treated previously with ALIMTA or irinotecan
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00034502
Study Brief:
Protocol Section:
NCT00034502